Non-small cell lung cancer

There are 208 papers on non-small cell lung cancer in aging research: 12 trials and 131 observational studies in people, 14 in animals, 11 in cells, 27 reviews. The newest story, Nov 17, 2026: “Pre-surgery program improved thinking scores after lung surgery”.

Disease

208 papers study it57 more mention it19 findings

13 new papers in 30 daysSee all 265 papers on non-small cell lung cancer

At a glance

Human studies link non-small cell lung cancer with cellular senescence in its microenvironment and clonal hematopoiesis with higher risk among never-smokers. A Mendelian randomization preprint links genetically predicted telomere length with higher risk. A mouse study reports reduced carcinogen-driven lung tumorigenesis with a PI3KDELTA inhibitor; a human study finds no clear link with dementia.

19 findings in 14 papers from 2016 to 2026, 4 of them since May 2026

“CHIP was associated with a greater risk of NSCLC in never-smoking participants (hazard ratio (HR)=1.76[1.07-2.89])”
Air pollution modifies clonal hematopoiesis-associated non-small cell lung cancer risk in non-smoking individualsJournal of the National Cancer Institute2026doi:10.1093/jnci/djag159
  • Human trial12
  • Humans131
  • Animals14
  • Cells11
  • In silico7

Interventions

1

PI3KDELTA inhibitor

downin mice1

1 study
  1. PI3KDELTA inhibitor decreases non-small cell lung cancer in mice (carcinogen-driven lung tumorigenesis).

    “Immune interception via phosphoinositide 3-kinase-δ (PI3Kδ) inhibition abrogated formation of Treg cell-rich iTLSs, reduced circulating and pulmonary Treg cells, increased local conventional type 1 dendritic cells (cDC1s) and reduced lung tumour incidence and size.”

    Animalscarcinogen-driven lung tumorigenesislung

    A preinvasive regulatory T cell axis for lung cancer interception

    Nature

More on PI3KDELTA inhibitor

Effects

3

Dementia

no changein humans1HR 1.11

1 study
  1. Non-small cell lung cancer was not clearly linked with dementia in humans (compared with matched non-cancer individuals) (adjusted HR = 1.11, 95% CI: 0.98-1.26).

    “stage II-III NSCLC was not associated with an increased risk of dementia compared with matched non-cancer individuals (adjusted HR = 1.11, 95% Confidence Interval (CI): 0.98-1.26).”

    Humanscompared with matched non-cancer individuals

    The Association of NSCLC and Dementia - A Population-Based Cohort Study in Taiwan

    Cancer investigation

More on Dementia

Cellular senescence

upin humans1

1 study
  1. Non-small cell lung cancer is linked with higher cellular senescence in NSCLC microenvironment.

    “T cells in the NSCLC microenvironment displayed increased senescent features (all P < 0.05).”

    Humansin NSCLC microenvironment

    Developing and experimental validating a T cell senescence-related gene signature to predict prognosis and immunotherapeutic sensitivity in non-small cell lung cancer

    Gene

More on Cellular senescence

Resting energy expenditure

upin humans1

1 study
  1. Non-small cell lung cancer is linked with higher resting energy expenditure in humans (7.5% higher than calculated REE).

    “mean measured REE was 7.5% higher than calculated REE”

    Humans

    Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer

    Annals of nutrition & metabolism

Associations

15

Smoking status

upin humans1OR 1.51

1 study
  1. Smoking status is associated with non-small cell lung cancer in humans (OR 1.51, 95% CI 1.04–2.19; nominal P = .030).

    “but reached only nominal significance for non-small cell LC (OR: 1.51, 95% CI: 1.04-2.19, P = .030), which did not survive correction”

    Humansever versus never smokers; nominal association did not survive multiple-testing correction or other estimatorsn = 1,627

    Contributions of smoking behaviour to lung cancer subtypes: A two-sample Mendelian randomization study

    Medicine

More on Smoking status

Smoking intensity

upin humans1OR 3.45

1 study
  1. Smoking intensity is linked with a higher risk of non-small cell lung cancer in humans (OR 3.45, 95% CI 2.30–5.18).

    “non-small cell LC (OR: 3.45, 95% CI: 2.30-5.18)”

    Humansper standard deviation increase in cigarettes smoked per dayn = 1,627

    Contributions of smoking behaviour to lung cancer subtypes: A two-sample Mendelian randomization study

    Medicine

More on Smoking intensity

Circulating eTreg cells

upin humans1

1 study
  1. Circulating eTreg cells are associated with non-small cell lung cancer in humans.

    “Emergence of this clonally coordinated eTreg cell circuit defined rapid progression in patients with early-stage NSCLC detected during CT screening.”

    Humans

    A preinvasive regulatory T cell axis for lung cancer interception

    Nature

More on Circulating eTreg cells

Clonal hematopoiesis of indeterminate potential

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of non-small cell lung cancer in humans (never-smoking participants).

    “CHIP was associated with a greater risk of NSCLC in never-smoking participants (hazard ratio (HR)=1.76[1.07-2.89])”

    Humansnever-smoking participants

    Air pollution modifies clonal hematopoiesis-associated non-small cell lung cancer risk in non-smoking individuals

    Journal of the National Cancer Institute

More on Clonal hematopoiesis of indeterminate potential

Suicide

upin humans1

1 study
  1. Non-small cell lung cancer is linked with a higher risk of suicide in humans (non-small cell lung cancer) (SMR 7.9, 95% CI 7.0-8.8).

    “The overall suicide SMR in NSCLC patients was 7.9 (95% confidence intervals [CI]: 7.0-8.8) times that of the general population.”

    Humansnon-small cell lung cancer

    A nomogram and standardized mortality ratio for suicide risk in middle-aged and elderly patients with non-small cell lung cancer in the United States

    Medicine

IL12B

downin humans1OR 0.9214

1 study
  1. IL12B is linked with a lower risk of non-small cell lung cancer in humans (OR = 0.9214, 95%CI 0.8571–0.9906).

    “IL-12β (OR = 0.9214, 95%CI 0.8571–0.9906, P = 0.0267) and TRAIL (OR = 0.9188, 95%CI 0.8479–0.9956, P = 0.0388) levels were negatively associated with risk”

    Humans

    Bidirectional Mendelian randomization identifies differential causal associations between inflammatory cytokines and lung cancer subtypes

    Discover oncology

More on IL12B

IL-17A + CTCs

upin humans1

1 study
  1. IL-17A + CTCs predicts non-small cell lung cancer in humans (diagnosis of early-stage NSCLC) (AUC 0.953, sensitivity 86.05%, specificity 90.00%).

    “The combination of IL-17 A and CTCs achieved an AUC of 0.953, with a sensitivity of 86.05% and specificity of 90.00%.”

    Humansdiagnosis of early-stage NSCLCblood

    Clinical value of CTCs combined with serum tumor markers/inflammatory cytokines for the early diagnosis of non-small cell lung cancer

    Immunobiology

More on IL-17A + CTCs

Interleukin-17A

upin humans1

1 study
  1. Interleukin-17A predicts non-small cell lung cancer in humans (diagnosis of early-stage NSCLC) (AUC 0.871, sensitivity 93.02%, specificity 75.00%).

    “IL-17 A exhibited the highest diagnostic efficacy for early-stage NSCLC, with an AUC of 0.871, sensitivity of 93.02%, and specificity of 75.00%.”

    Humansdiagnosis of early-stage NSCLCserum

    Clinical value of CTCs combined with serum tumor markers/inflammatory cytokines for the early diagnosis of non-small cell lung cancer

    Immunobiology

More on Interleukin-17A

CTCs + CEA + CYFRA21-1 + NSE

upin humans1

1 study
  1. CTCs + CEA + CYFRA21-1 + NSE predicts non-small cell lung cancer in humans (diagnosis of early-stage NSCLC) (AUC 0.945, sensitivity 86.05%, specificity 100.00%).

    “The combined diagnostic sensitivity of CTCs, CEA, CYFRA21-1, and NSE reached 86.05%, with 100.00% specificity and an AUC of 0.945.”

    Humansdiagnosis of early-stage NSCLCblood

    Clinical value of CTCs combined with serum tumor markers/inflammatory cytokines for the early diagnosis of non-small cell lung cancer

    Immunobiology

More on CTCs + CEA + CYFRA21-1 + NSE

Circulating tumor cells

upin humans1

1 study
  1. Circulating tumor cells predict non-small cell lung cancer in humans (diagnosis of early-stage NSCLC) (AUC 0.826, sensitivity 65.12%, specificity 100.00%).

    “CTCs exhibited a sensitivity of 65.12%, specificity of 100.00%, and an area under the curve (AUC) of 0.826 for the diagnosis of early-stage NSCLC”

    Humansdiagnosis of early-stage NSCLCblood

    Clinical value of CTCs combined with serum tumor markers/inflammatory cytokines for the early diagnosis of non-small cell lung cancer

    Immunobiology

More on Circulating tumor cells

All 15

Trial sponsors

Funding

5 grants since 2021

National Institute on Aging$355KNational Cancer Institute$393KUS Department of Veterans Affairs

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies link non-small cell lung cancer with cellular senescence in its microenvironment and peripheral-blood S100P hypomethylation. In men, FOXO3 is associated with lower risk among former smokers, while smoking cessation is associated with lower risk among FOXO3-G carriers. A mouse study reports reduced carcinogen-driven lung tumorigenesis with PI3KDELTA inhibition.

  2. Summary rewritten as its findings changed.

    As it read before

    Human studies associate smoking cessation with lower non-small cell lung cancer risk in male FOXO3-G carriers, and FOXO3 with lower risk in male former smokers. Circulating eTreg cells are also associated with the disease in humans. In mice, a PI3KDELTA inhibitor reduces carcinogen-driven lung tumorigenesis.

  3. Summary written from the findings.

Latest

Dec 2025: 7Jan 2026: 9Feb 2026: 14Mar 2026: 13Apr 2026: 5May 2026: 4Jun 2026: 3Jul 2026: 4Aug 2026: 4Sep 2026: 5Oct 2026: 6Nov 2026: 680 papers in 12 months
Journal of Clinical Medicine

Pre-surgery program improved thinking scores after lung surgery

Soon after surgery, cognitive test scores were 83.8 with the two-week program versus 78.5 with standard care; benefits persisted at two months.Soon after surgery, cognitive test scores were 83.8 with the two-week program versus 78.5 with standard care; benefits persisted at two months.

Randomized trial · 77 peopleLung
Biochimica et Biophysica Acta Molecular Basis of Disease

Lung cancer outcomes linked to senescence in blood vessel cells

An observational analysis linked senescence in blood-vessel-lining cells to better immunotherapy responses and longer survival in people with non-small cell lung cancer.An observational analysis linked senescence in blood-vessel-lining cells to better immunotherapy responses and longer survival in people with non-small cell lung cancer.

Study in peopleCellular senescence

See all 265 papers on non-small cell lung cancer